摘要
在外科的结果评价传统地包括了考虑的数据在外科的肿瘤学的仙子起作用的死亡和病态，以及长期的幸存和复发。然而，生命(QOL ) 的质量是另一项重要病人相关的结果措施。QOL 数据能被用来定制治疗并且由在可能不那样被俯看的病人检测物理或心理的问题改进临床的结果，但是它为照顾的有效交货有深刻含意。我们考察仪器与胃肠的恶意在病人为使用明确地开发了的几验证得好的 QOL，包括食道，胰腺并且渲染表面的癌症，并且断定 QOL 评价应该习惯性地在新奇治疗的临床的试用被包括。
Outcomes assessment in surgery traditionally has included data regarding peri-operative mortality and morbidity, as well as long-term survival and recurrence in surgical oncology. However, quality of life （QOL） is another important patient-related outcome measure. QOL data can be used to tailor treatment and improve clinical outcomes by detecting physical or psychological problems in patients that otherwise might be overlooked, but which have profound implications for the effective delivery of care. We review several well-validated QOL instruments developed specifically for use in patients with gastrointestinal malignancies, including esophageal, pancreatic and colorectal cancers, and conclude that QOL assessment routinely should be included in clinical trials of novel treatments.
